Comparative Clinical Study of Pharmacokinetics, Tolerance and Safety of BCD-057 and Humira in Healthy Volunteers
- First Posted Date
- 2015-03-20
- Last Posted Date
- 2021-11-05
- Lead Sponsor
- Biocad
- Target Recruit Count
- 94
- Registration Number
- NCT02395055
- Locations
- 🇷🇺
LLC BioEk, Saint-Petersburg, Russian Federation
First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy Subjects
- Conditions
- Healthy
- Interventions
- Drug: humanized monoclonal antibody against human IL-17
- First Posted Date
- 2015-03-05
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Biocad
- Target Recruit Count
- 22
- Registration Number
- NCT02380287
A Safety and Efficacy Study of BCD-080 Compared to Clexan for Deep Vein Thrombosis Prophylaxis at Orthopedic Surgeries
- Conditions
- Deep Vein Thrombosis
- Interventions
- Drug: Sodium Enoxaparine
- First Posted Date
- 2015-02-23
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Biocad
- Target Recruit Count
- 124
- Registration Number
- NCT02368314
- Locations
- 🇷🇺
Railroad Clinical Hospital at the station Chelyabinsk, Chelyabinsk, Russian Federation
Open Label Study of Tolerability, Pharmacokinetics and Pharmacodynamics of BCD-054 (Pegylated Interferon Beta-1a), IM and SC, Compared to Rebif® and Avonex® in Healthy Volunteers
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- Biocad
- Target Recruit Count
- 60
- Registration Number
- NCT02359877
- Locations
- 🇷🇺
OOO "BioEk", Saint-Petersburg, Russian Federation
Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis
- Conditions
- Ankylosing Spondylitis
- Interventions
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2016-06-08
- Lead Sponsor
- Biocad
- Target Recruit Count
- 90
- Registration Number
- NCT02359903
- Locations
- 🇧🇾
Vitebsk Regional Clinical Hospital, Vitebsk, Belarus
🇷🇺Chelyabinsk Regional Clinical hospital, Chelyabinsk, Russian Federation
🇷🇺Research Institute of Rheumotology, Moscow, Russian Federation
Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients
- Conditions
- Chemotherapy-induced Neutropenia
- First Posted Date
- 2014-04-04
- Last Posted Date
- 2016-10-24
- Lead Sponsor
- Biocad
- Target Recruit Count
- 135
- Registration Number
- NCT02104830
- Locations
- 🇷🇺
Arkhangelsk District Clinical Oncology Dispensary, Arkhangelsk, Russian Federation
🇷🇺Clinical Hospital at Chelyabinsk Railway Station, Chelyabinsk, Russian Federation
🇷🇺State public health institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of the Republic of Tatarstan, Kazan, Russian Federation
An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients
- Conditions
- Hepatitis CHepatitis C/ Human Immunodeficiency Virus CoinfectionHepatitis
- Interventions
- First Posted Date
- 2014-04-03
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Biocad
- Target Recruit Count
- 140
- Registration Number
- NCT02103439
- Locations
- 🇷🇺
State Public Healthcare Institution National Center for the Prevention and Control of AIDS and other infectious diseases of the Ministry of Health of the Republic of Tatarstan, Kazan, Republic Of Tatarstan, Russian Federation
🇷🇺State Institution of Nizhny Novgorod region "Regional Center for Prevention and Control of AIDS and other infectious diseases", Nizhny Novgorod, Russian Federation
🇷🇺State Healthcare Institution Center for the Prevention and Control of AIDS and infectious diseases of the city, St.Petersburg CityHealth Department, Sankt-Petersburg, Russian Federation
Safety and Efficacy Study of BCD-021 Compared to Lucentis® in Patients With Neovascular Wet Age-related Macular Degeneration
- Conditions
- Wet Age-related Macular Degeneration
- Interventions
- First Posted Date
- 2014-01-15
- Last Posted Date
- 2016-03-31
- Lead Sponsor
- Biocad
- Registration Number
- NCT02036723
- Locations
- 🇧🇷
Universidade Estadual de Londrina, Londrina, Parana, Brazil
🇧🇷Hospital dos Olhos do Paraná, Curitiba, Paraná, Brazil
🇧🇷Universidade Federal de Minas Gerais Hospital das Clínicas, Belo Horizonte, Brazil
An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C
- First Posted Date
- 2013-06-28
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- Biocad
- Target Recruit Count
- 170
- Registration Number
- NCT01889433
- Locations
- 🇧🇾
Gomel Regional Clinical Hospital, Gomel, Belarus
🇧🇾Vitebsk Regional Clinical Hospital, Vitebsk, Belarus
🇮🇳Suyash Hospital Pvt. Ltd. Opposite M.G.M Medical College A.B. Road, Indore, India
Pharmacokinetics and Pharmacodynamics Study of BCD-033 Compared to Rebif® in Healthy Volunteers
- First Posted Date
- 2013-01-11
- Last Posted Date
- 2016-05-04
- Lead Sponsor
- Biocad
- Target Recruit Count
- 32
- Registration Number
- NCT01766024
- Locations
- 🇷🇺
City Mariin Hospital, St. Petersburg, Russian Federation